Publications

Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya.

BESHIR, KB; Sepúlveda, N; BHARMAL, J; ROBINSON, A; Mwanguzi, J; Busula, AO; De Boer, JG; SUTHERLAND, C; Cunningham, J; HOPKINS, H;

2017

Scientific reports, (2017).7 1 10.1038/s41598-017-15031-2.

Magnetic Resonance Imaging of Cerebral Malaria Patients Reveals Distinct Pathogenetic Processes in Different Parts of the Brain.

Mohanty, S; Benjamin, LA; Majhi, M; Panda, P; Kampondeni, S; Sahu, PK; Mohanty, A; Mahanta, KC; Pattnaik, R; Mohanty, RR; Joshi, S; Mohanty, A; Turnbull, IW; Dondorp, AM; Taylor, TE; WASSMER, SC;

2017

mSphere, (2017).2 3 10.1128/mSphere.00193-17.

Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence.

Schallig, HD; Tinto, H; Sawa, P; KAUR, H; Duparc, S; Ishengoma, DS; Magnussen, P; Alifrangis, M; SUTHERLAND, CJ;

2017

BMJ global health, (2017).2 3 10.1136/bmjgh-2017-000371.

The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia.

TADESSE, FG; VAN DEN HOOGEN, L; Lanke, K; Schildkraut, J; TETTEH, K; Aseffa, A; Mamo, H; Sauerwein, R; Felger, I; DRAKELEY, C; Gadissa, E; BOUSEMA, T;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1749-4.

Corrigendum to "Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes" [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174-180].

Gomes, AR; RAVENHALL, M; Benavente, ED; Talman, A; SUTHERLAND, C; ROPER, C; CLARK, TG; CAMPINO, S;

2017

International journal for parasitology Drugs and drug resistance, (2017).7 3 10.1016/j.ijpddr.2017.11.001.

Insecticide-treated nets provide protection against malaria to children in an area of insecticide resistance in Southern Benin.

BRADLEY, J; Ogouyèmi-Hounto, A; Cornélie, S; Fassinou, J; De Tove, YS S; Adéothy, AA; Tokponnon, FT; Makoutode, P; Adechoubou, A; Legba, T; Houansou, T; Kinde-Gazard, D; Akogbeto, MC; Massougbodji, A; Knox, TB; Donnelly, M; KLEINSCHMIDT, I;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1873-1.

Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.

VAN SCHALKWYK, DA; MOON, RW; Blasco, B; SUTHERLAND, CJ;

2017

The Journal of antimicrobial chemotherapy, (2017).72 11 10.1093/jac/dkx279.

Introducing malaria rapid diagnostic tests in private medicine retail outlets: A systematic literature review.

Visser, T; BRUXVOORT, K; Maloney, K; Leslie, T; Barat, LM; Allan, R; Ansah, EK; Anyanti, J; Boulton, I; CLARKE, SE; Cohen, JL; Cohen, JM; Cutherell, A; Dolkart, C; Eves, K; Fink, G; GOODMAN, C; HUTCHINSON, E; LAL, S; Mbonye, A; Onwujekwe, O; Petty, N; Pontarollo, J; Poyer, S; SCHELLENBERG, D; ... CHANDLER, CI R.

2017

PloS one, (2017).12 3 10.1371/journal.pone.0173093.

Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions.

Mwesigwa, J; ACHAN, J; Di Tanna, GL; Affara, M; Jawara, M; Worwui, A; Hamid-Adiamoh, M; Kanuteh, F; Ceesay, S; Bousema, T; DRAKELEY, C; Grietens, KP; Lindsay, SW; Van Geertruyden, J-P; D'ALESSANDRO, U;

2017

PloS one, (2017).12 11 10.1371/journal.pone.0187059.

Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries.

ACTwatch Group,; Newton, PN; HANSON, K; GOODMAN, C;

2017

Malaria journal, (2017).16 1 10.1186/s12936-017-1818-8.